We hypothesized that those genes with increased expression at both mRNA and protein levels (namely with high transcriptional and translational activities) in ESCC tumors acted as core upstream signals that led to the observed difference in posttranscriptional modulation between ESCC and NAT tissues. This evidence concerns the gene BRD2 and esophageal squamous cell carcinoma.